Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates

Materials Today Bio(2025)10.1016/j.mtbio.2025.102698Source: DataRank Database

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates is a research paper published in Materials Today Bio (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

Replication Data for: Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates · CORA.Repositori de Dades de Recerca

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 0.00)OA: goldTopics (18)Linked Datasets (1)DataCite Reuse (1)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Annabel García‐León ORCID,Lourdes A. Arena,Julián I. Mendoza ORCID,Anna Aviñó ORCID,Carme Fàbrega ORCID

Live enrichment

PubMed:41560806 PMC:PMC12813365 OpenAlex:https://openalex.org/W4417488646

National Institutes of Health

Grant: R 01-GM129325

State Agency of Research

Grant: CNS2024-154280

State Agency of Research

Grant: PDC2022-133858-I00

Fundación La Caixa

Grant: LCF/BQ/DI24/12070029

AGAUR

Grant: SGR-00092

AGAUR

Grant: 2021 SGR-01140

Carlos III Health Institute

Grant: PI21/00150

Carlos III Health Institute

Grant: CP24/00111

Carlos III Health Institute

Grant: PI24/01476

Carlos III Health Institute

Grant: PI24/00012

Carlos III Health Institute

Grant: FI21/00012

Carlos III Health Institute

Grant: PI20/00400

Carlos III Health Institute

Grant: PI23/00318

Carlos III Health Institute

Grant: CP19/00028

European Social Fund Plus

National Institute of Allergy and Infectious Diseases

European Regional Development Fund

'la Caixa' Foundation

Generalitat de Catalunya

International Centre for Theoretical Sciences

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina

FWCI

0.00

Citation Percentile

0.4%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.mtbio.2025.102698

publisherhttps://doi.org/10.1016/j.mtbio.2025.102698

publisherhttps://api.elsevier.com/content/article/PII:S2590006425012700?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2590006425012700?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41560806

Fields of Study

HER2/EGFR in Cancer ResearchNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Keywords

NanocarriersBiodistributionConjugatePharmacokineticsPeptideDrug deliveryLigand (biochemistry)CancerTargetingCancer therapyBioconjugationMultivalencyDose-sparingProtein NanocarriersPrecision Nanomedicine

Replication Data for: Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates

10.34810/data2902CORA.Repositori de Dades de Recerca

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates

FAIR Checklist

Authors (14)

Funding (21 grants)

Impact

Open Access

Topics

Linked Datasets (1)

Annotations (Europe PMC)